Vimarsana
Biggest News Aggregation in the World

Page 17 - Numinus Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Numinus Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Numinus Bioscience Today - Breaking & Trending Today

FinancialNewsMedia.com: Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues - Vimarsana News

FinancialNewsMedia.com: Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues

PALM BEACH, Fla., Oct. 28, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential…

NA Proactive news snapshot: Nova Royalty Corp, Lucky Minerals Inc, PyroGenesis Canada Inc, GreenBank Capital Inc, Pathfinder Ventures Inc, Thunderbird Entertainment Group Inc, Numinus Wellness Inc, ESE Entertainment Inc, Heritage Cannabis Holding Corp, Al - Vimarsana News

NA Proactive news snapshot: Nova Royalty Corp, Lucky Minerals Inc, PyroGenesis Canada Inc, GreenBank Capital Inc, Pathfinder Ventures Inc, Thunderbird Entertainment Group Inc, Numinus Wellness Inc, ESE Entertainment Inc, Heritage Cannabis Holding Corp, Al

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

NA Proactive news snapshot: Thunderbird Entertainment Group Inc, Numinus Wellness Inc, ESE Entertainment Inc, Heritage Cannabis Holding Corp, Alpine 4 Holdings, Inc UPDATE ... - Vimarsana News

NA Proactive news snapshot: Thunderbird Entertainment Group Inc, Numinus Wellness Inc, ESE Entertainment Inc, Heritage Cannabis Holding Corp, Alpine 4 Holdings, Inc UPDATE ...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product - Vimarsana News

Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

Finalized study design and protocol mark major milestone to investigate natural Psilocybin Numinus Wellness Inc.  a leader in psychedelics-focused mental healthcare, is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin extract, previously announced on April 26, 2021 . This major milestone advances Numinus' investigation of its first proprietary ...

Numinus Wellness Inc. advances Phase 1 trial on its proprietary psilocybin product PSYBINA - Vimarsana News

Numinus Wellness Inc. advances Phase 1 trial on its proprietary psilocybin product PSYBINA

The company said the finalized study design and protocol mark a major milestone to investigate natural psilocybin